loader
Please Wait
Applying Filters...
menu
    • menu

    FDA Approvals: Strides' Generic Dutasteride approved in US for Gastric Ulcer - Strides Pharma Science

    MenuStrides Pharma Science

    Uploaded: 2018
    News
    Strides Pharma Reports Q2 FY25 Consolidated PAT of Rs. 93.23 Cr

    28 Oct 2024

    // #N/A

    Strides Pharma reports Q2 FY25 consolidated PAT at Rs. 93.23 Cr

    24 Oct 2024

    // PRESS RELEASE

    OneSource receives equity of Rs 8,010 Mn at a pre-money equity

    18 Oct 2024

    // PRESS RELEASE

    DATA COMPILATION
    #PharmaFlow

    Strides Pharma Science

    Contact Supplier

    Website

    CPhI India 2024

    Attending

    Book a meeting

    envelop Contact Supplier

    Latest Content by PharmaCompass

    Xls

    CATEGORY PAGE
    Menu

    Strides Pharma Science

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    Key Products KEY PRODUCTS

    INSPECTIONS & REGISTRATIONS

    PharmaCompass
    PC110726